Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 6/20 | 0.68 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.51 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.51 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.51 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.49 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.49 |
| ▸ | WDR5 | P61964 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20602561 | 0.82 | CYP11B1 (0.61) | TBXAS1CYP11B1CYP11B2CYP19A1LMNA | |
| Hydrochloric Acid SCHEMBL11477573 | 0.81 | TBXAS1 (1.00) | TBXAS1CYP11B1CYP11B2CYP19A1LMNA | |
| SCHEMBL20623015 | 0.80 | CYP11B1 (0.58) | TBXAS1CYP11B1CYP11B2CYP19A1LMNA | |
| SCHEMBL11477599 | 0.76 | TBXAS1 (1.00) | TBXAS1CYP11B1CYP11B2CYP19A1LMNA | |
| SCHEMBL10664980 | 0.76 | CYP11B1 (0.70) | TBXAS1CYP11B1CYP11B2CYP19A1CYP2A6 | |
| SCHEMBL11477428 | 0.76 | TBXAS1 (0.67) | TBXAS1CYP11B1CYP11B2CYP19A1LMNA | |
| SCHEMBL284240 | 0.76 | SMN1; SMN2 (0.68) | TBXAS1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL11485144 | 0.75 | TBXAS1 (1.00) | TBXAS1CYP11B1CYP11B2CYP19A1LMNA | |
| SCHEMBL15190312 | 0.75 | HPGD (0.69) | CYP19A1MEN1KMT2A | |
| SCHEMBL11477508 | 0.74 | TBXAS1 (0.64) | TBXAS1CYP11B1CYP11B2CYP19A1CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10927100-B2 | Degradable imidazolium oligomer and polymer for antimicrobial applications | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2021-02-23 | — | — | US | disclosed |
| US-20200181122-A1 | Degradable Imidazolium Oligomer and Polymer for Antimicrobial Applications | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2020-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10927100-B2 | Degradable imidazolium oligomer and polymer for antimicrobial applications | NOD2, CFTR, PUF60 | TBXAS1 2982/4885CYP11B1 3790/4885CYP11B2 3749/4885 |
| US-20200181122-A1 | Degradable Imidazolium Oligomer and Polymer for Antimicrobial Applications | NOD2, CFTR, PUF60 | TBXAS1 2982/4885CYP11B1 3790/4885CYP11B2 3749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.